Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Outcomes for patients with advanced-stage Hodgkin's lymphoma have improved dramatically over the past half century. Although regional differences exist, the most commonly used frontline regimen — doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) — has not been modified since its original…

http://ift.tt/2ychtui